Trials / Conditions / Platelet Reactivity

Platelet Reactivity

15 registered clinical trials studyying Platelet Reactivity.

Status	Trial	Sponsor	Phase
Unknown	Pharmacodynamic Outcomes in CCS Patients Treated With an Individualized Treatment Strategy NCT05773989	St. Antonius Hospital	Phase 4
Unknown	Body Weight Adjusted Clopidogrel Treatment in Patients With CORonary Artery Disease NCT05657041	St. Antonius Hospital	Phase 2 / Phase 3
Terminated	Platelet Reactivity With Fentanyl, Morphine, or no Narcotic NCT05367336	Corewell Health South	Phase 2
Completed	Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease NCT04001894	First Affiliated Hospital of Harbin Medical University	Phase 4
Unknown	Platelet Reactivity And Clinical ThrombotIC Events Study NCT03525145	Shenyang Northern Hospital	—
Completed	Low-dose of Ticagrelor and Standard-dose Clopidogrel on Platelet Effects in Chinese Patients With Stable CAD. NCT03679091	First Affiliated Hospital of Harbin Medical University	Phase 4
Unknown	Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHD NCT03614832	First Affiliated Hospital of Harbin Medical University	Phase 4
Unknown	Is There a Transient Rebound Effect of Platelet Reactivity Following Cessation of Dual Antiplatelet Therapy Wi NCT02808039	Rabin Medical Center	—
Completed	Ticagrelor Loading Dose Versus Clopidogrel Loading and Reloading With Ticagrelor. NCT01961856	University of Patras	Phase 3
Completed	High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarct NCT01835353	University of Patras	Phase 3
Completed	Ticagrelor in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis NCT01511471	University of Patras	Phase 3
Completed	Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <6 NCT01463150	University of Patras	Phase 4
Completed	Ticagrelor in Comparison to Prasugrel for Early Inhibition of Platelet Reactivity in Patients With ST-elevatio NCT01463163	University of Patras	Phase 4
Completed	Platelet Hyperreactivity Project NCT00976196	Pierre Fontana	—
Completed	Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary NCT00827346	Ottawa Heart Institute Research Corporation	Phase 2 / Phase 3